(Q55025577)

English

Negative p53/positive p21 immunostaining is a predictor of favorable response to chemotherapy in patients with locally advanced bladder cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/PMC/5926463

Negative p53/positive p21 immunostaining is a predictor of favorable response to chemotherapy in patients with locally advanced bladder cancer. (English)

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/PMC/5926463

1 reference

based on heuristic

inferred from title

author name string

F Koga

1

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/PMC/5926463

S Kitahara

2

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/PMC/5926463

K Arai

3

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/PMC/5926463

M Honda

4

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/PMC/5926463

S Sumi

5

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/PMC/5926463

K Yoshida

6

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/PMC/5926463

publication date

1 April 2000

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/PMC/5926463

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Japanese Journal of Cancer Research

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/PMC/5926463

91

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/PMC/5926463

416-423

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/PMC/5926463

4

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/PMC/5926463

Absence of p53 overexpression and favorable response to cisplatin-based neoadjuvant chemotherapy in urothelial carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

16 June 2018

The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

16 June 2018

p53 nuclear immunoreactivity as a predictor of response and outcome following chemotherapy for metastatic bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

16 June 2018

Combined-modality therapy for bladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

16 June 2018

Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21/WAF1/CIP1 and/or p53 gene alterations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

16 June 2018

Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

16 June 2018

Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

16 June 2018

p21 is a universal inhibitor of cyclin kinases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

16 June 2018

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

16 June 2018

The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

16 June 2018

Induction of WAF1/CIP1 by a p53-independent pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

16 June 2018

p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

16 June 2018

The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

16 June 2018

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

13 August 2018

WAF1/CIP1 increases the susceptibility of p53 non-functional malignant glioma cells to cisplatin-induced apoptosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

13 August 2018

A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

13 August 2018

Accumulation of nuclear p53 and tumor progression in bladder cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926463

13 August 2018

Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2000.TB00961.X

21 January 2018

p53 and treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2000.TB00961.X

21 January 2018

WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/10804290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Balloon-occluded arterial infusion as a useful neoadjuvant chemotherapy for bladder cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10804290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of p21WAF1/CIP1 in primary bladder tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10804290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 mutations and prognosis in bladder tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10804290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical significance of p21(WAF1/CIP-1) and p53 expression in pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10804290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/10804290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC

1 reference

https://pubmed.ncbi.nlm.nih.gov/10804290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant m-vac (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/10804290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular analysis of the Cip1/Waf1 (p21) gene in diverse types of human tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10804290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1349-7006.2000.TB00961.X

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/PMC/5926463

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/PMC/5926463

1 reference

Europe PubMed Central

15 June 2018

http://europepmc.org/abstract/PMC/5926463

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55025577&oldid=1770202510"